KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueDepreciation ExpenseEBIATLeasesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables RefundsShares Issued
Ratios

Globus Medical (GMED) Receivables Refunds (2016 - 2025)

Globus Medical's Receivables Refunds history spans 15 years, with the latest figure at $64.7 million for Q4 2025.

  • For Q4 2025, Receivables Refunds rose 213.71% year-over-year to $64.7 million; the TTM value through Dec 2025 reached $64.7 million, up 213.71%, while the annual FY2025 figure was $64.7 million, 213.71% up from the prior year.
  • Receivables Refunds reached $64.7 million in Q4 2025 per GMED's latest filing, down from $69.0 million in the prior quarter.
  • In the past five years, Receivables Refunds ranged from a high of $69.0 million in Q3 2025 to a low of $366000.0 in Q1 2024.
  • Average Receivables Refunds over 5 years is $13.9 million, with a median of $3.3 million recorded in 2022.
  • Peak YoY movement for Receivables Refunds: soared 2043.21% in 2021, then plummeted 87.97% in 2024.
  • A 5-year view of Receivables Refunds shows it stood at $1.2 million in 2021, then surged by 234.24% to $4.1 million in 2022, then plummeted by 59.74% to $1.6 million in 2023, then surged by 1161.96% to $20.6 million in 2024, then skyrocketed by 213.71% to $64.7 million in 2025.
  • Per Business Quant, the three most recent readings for GMED's Receivables Refunds are $64.7 million (Q4 2025), $69.0 million (Q3 2025), and $48.6 million (Q2 2025).